Page 13 - Les Meilleurs doctors pour votre Ultrason - TOP 502 des médecins

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Diagnostic et traitements de la maladie de Parkinson

Diagnostic et traitements de la maladie d'Alzheimer

Épilepsie (épileptique)

EEG et traitement

Diagnostic et traitements des maladies musculaires et nerveuses

Diagnostic et traitement du vertige

Syndrome des jambes sans repos

Diagnostic et traitement de l'AVC (paralysie cérébrale)

Hôpital d'État de Bartın (2007-2009)

Hôpital VM Medical Park Samsun (2009-2017)

Hôpital VM Medical Park Samsun - Médecin-chef adjoint (2019-2021)

Hôpital d'enseignement et de recherche de Samsun (2021-2022)

Hôpital d'État de Çarşamba

Hôpital privé Atasam Samsun (2022-2024)

Université Technique de Karadeniz (1989-1995)

Faculté de médecine de l'Université Ondokuz Mayis (2001-2006)

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. José Miguel Esteban López-Jamar is a gastroenterologist. He has led the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional since 2007. He has more than 20 years of experience. He is a Spanish pioneer in endoscopic ultrasound (EUS). His work covers diagnostic and interventional endoscopy. He uses innovative, minimally invasive techniques for complex gastrointestinal disease.

He was Head of Endoscopy (2008–2012) and Head of Endoscopic Innovation (2012–2014) at Hospital Clínico San Carlos. He completed international training at AMC Amsterdam, Institut Paoli-Calmettes in Marseille, and Zhongshan Hospital in Shanghai. He holds an MD and a PhD from the Complutense University of Madrid. He is a specialist in gastroenterology. He takes part in multicenter European studies and clinical trials. He is a member of SEPD, SEED, and ESGE.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

 Publications et affiliations

Directeur clinique – Unité multidisciplinaire de soins du sein, Clinique Essen-Mitte, Allemagne

Diriger le programme de recherche sur le cancer du sein, Kliniken Essen-Mitte

Membre du conseil d'administration de l'AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Rôles supplémentaires

Faculté ESMO – Cancer du Sein

Membre de l'AWO Gyn – Commission de chirurgie plastique et reconstructive

Orateur de l'AGIMed – Commission de Médecine Intégrative de l'AGO

Membre de la Commission d'orgue Mamma de l'AGO

Directeur scientifique du groupe d'étude WSG

PI mondial, Responsable des investigations et essais cliniques 27

IDMC, comités directeurs nationaux et internationaux

Comité scientifique des symposiums internationaux et nationaux sur le cancer du sein et l'oncologie chirurgicale

 Adhésions à des organisations

Adhésions : Société européenne d'oncologie médicale, Société américaine d'oncologie clinique,

Académie européenne de sénologie, Société allemande du cancer, Société allemande de gynécologie et

Obstétrique, Groupe de travail pour l'oncologie gynécologique, Société allemande de sénologie,

 Publications

Publications évaluées par des pairs : 322

Premier/auteur principal : 38

Indice h/indice i10 66/232

Résumés/Actes du Congrès : 443

Livres/Chapitre de livre : 59

Présentations orales/conférences invitées : 1032

informations générales

Radiologue musculo-squelettique, expert en blessures sportives et en imagerie par résonance magnétique avec plus de 20 ans d'expérience auprès d'athlètes professionnels et d'élite.

Expérience professionnelle

• Fondateur : Elite Sports Imaging, SL, Madrid, Espagne.
• Médecin consultant : Open de Madrid (tournoi de tennis).
• Consultant : Longwood MRI Specialists, Boston, États-Unis.
• Directeur de l'IRM musculo-squelettique et de la TDM : Massachusetts General Hospital/Harvard Medical School (2002–2006).

Éducation et qualifications

• Université de Californie, Los Angeles (UCLA) : Bachelor of Science en kinésiologie et sciences de l'exercice (BS).
• École de médecine de l'Université McGill : Docteur en médecine et maîtrise en chirurgie (MD, CM).
• Université de Boston/Centre médical de Boston : résidence en radiologie.
• Harvard Medical School/Massachusetts General Hospital : bourse de recherche en radiologie musculo-squelettique et radiologie interventionnelle.
• Massachusetts Institute of Technology (MIT)/m+Visión : Bourse postdoctorale en recherche biomédicale en imagerie médicale.

Particularités de l'activité professionnelle

Le médecin est spécialisé dans :

• Diagnostic et traitement des blessures sportives par IRM et TDM.
• Mise en œuvre de technologies avancées dans le domaine de la visualisation du système musculo-squelettique.
• Une approche personnalisée pour diagnostiquer les blessures chez les athlètes d’élite.

Le médecin possède une expérience exceptionnelle de travail dans des institutions mondiales de premier plan telles que la Harvard Medical School et le MIT, ce qui lui permet de combiner la pratique clinique, la recherche scientifique et l’application de méthodes innovantes en imagerie médicale.

Formation et expertise

• 2010-2016 – FACULTÉ DE MÉDECINE DE L'UNIVERSITÉ EGE
• 2017-2022 – Faculté de médecine de l'Université EGE, division de radiologie

Maladies

• Radiologie abdominale
• Radiologie du sein

Méthodes de traitement

• Biopsies mammaires et thyroïdiennes
• Procédures interventionnelles non vasculaires et biopsies
• Procédures de drainage percutané

Expérience

• 2016-2017 – Hôpital d'État d'Uşak (médecin généraliste)
• 2017-2022 – Université d'Ege (Formation de spécialisation)
• 2022-2024 – Hôpital de formation et de recherche d'Ağrı (médecin spécialiste)

Adhésions professionnelles

• Association turque de radiologie (TRD)
• Société turque de radiologie interventionnelle (TGRD)

Éducation

Diplôme en médecine et chirurgie (MBBS) Faculté de médecine de l'Université de Pérouse, Italie. (2000-2006)

Stage au Département de chirurgie cardiaque, Hôpital universitaire « S. Maria della Misericordia », Pérouse, Italie. (2005 – 2006)

Inscription clinique en médecine et chirurgie, hôpital universitaire « S. Maria della Misericordia », Pérouse, Italie. (2006 – 2007)

Achèvement des examens d'État pour la profession médicale et chirurgicale (Esame di Stato). Notes 262,5 / 270. Faculté de médecine de l'Université de Pérouse, Italie. (Juin 2007)

Certificat de fin de formation (CCT) en chirurgie cardiaque. Note 50/50. Thèse : « Implantation de valve aortique par voie transcathéter (TAVI) – Une expérience dans un seul centre ». Département de chirurgie cardio-thoracique, hôpital universitaire « San Matteo », Pavie, Italie. (Juillet 2014)

Formation et expérience professionnelle

Chercheur clinique junior en chirurgie cardiaque, Département de chirurgie cardiaque, Hôpital universitaire « S. Maria della Misericordia », Pérouse, Italie. (2007 – 2008)

Assistant clinicien en chirurgie cardiaque, Département de chirurgie cardiaque, Hôpital universitaire « S. Maria della Misericordia », Pérouse, Italie. (2008 – 2009)

Résident en chirurgie cardiaque (CTh), Département de chirurgie cardio-thoracique, Hôpital universitaire « San Matteo », Pavie, Italie. (2009 – 2014)

Représentant des stagiaires en chirurgie cardiaque et membre du conseil d’administration de l’École de chirurgie cardiaque. Hôpital universitaire « San Matteo », Pavie, Italie. (2011 – 2014)

Bourse de recherche en transplantation cardiaque, Département de chirurgie cardio-thoracique, Hôpital universitaire « San Matteo », Pavie, Italie. (2011 – 2012)

Bourse de recherche en implantation de valve aortique par voie transcathéter (TAVI), Département de chirurgie cardio-thoracique, hôpital universitaire « San Matteo », Pavie, Italie. (2013 – 2014)

Médecin-chef résident en chirurgie cardiaque, département de chirurgie cardio-thoracique, hôpital universitaire « San Matteo », Pavie, Italie. (2013 – 2014)

Bourse de recherche en chirurgie cardiaque adulte, département de chirurgie cardio-thoracique, hôpital universitaire St. Georges, Londres, Royaume-Uni. (2014 – 2015)

Médecin spécialiste senior en chirurgie cardiaque, département de chirurgie cardio-thoracique, hôpital universitaire de Hull et de l'East Yorkshire, Hull, Royaume-Uni. (2015 – 2022)

Responsable des médecins nommés par le Trust auprès du SCTS pour l'unité cardio-thoracique, département de chirurgie cardio-thoracique, hôpital universitaire de Hull et de l'East Yorkshire, Hull, Royaume-Uni. (2020 – 2022)

Directeur de l'unité de chirurgie cardiaque, Institut médical allemand, Limassol, Chypre. (2022 – présent)

Activité scientifique

Doctorat en médecine : Thèse : « L’importance du moment chirurgical sur le résultat postopératoire chez les patients atteints d’endocardite aiguë de la valve native ». Faculté de médecine de l’Université de Pérouse, Italie. (Avril 2005 – Décembre 2006)

Collaborateur au projet national multicentrique « Effets de la pandémie de Covid-19 sur la prestation de services de chirurgie cardiaque au Royaume-Uni ». Département de chirurgie cardio-thoracique, hôpital universitaire de Hull et de l'East Yorkshire, Hull, Royaume-Uni. (2020 – 2022)

Co-investigateur dans l'essai contrôlé randomisé international multicentrique (ECR) COMICs comparant le mini-bypass (MIECC) au pontage conventionnel. Département de chirurgie cardio-thoracique, hôpital universitaire de Hull et de l'East Yorkshire, Hull, Royaume-Uni. (2018 – 2022)

Co-investigateur au registre international multicentrique ROUTE, dont l'objectif était d'analyser l'efficacité et la sécurité du TAVI transaortique (TAo) comme approche de première intention et de le comparer aux patients recevant le TAo-TAVI en dernier recours, ce qui est la pratique courante. Département de chirurgie cardio-thoracique, hôpital universitaire « San Matteo », Pavie, Italie. (2013 – 2014)

Intérêt particulier

Revascularisation myocardique (pontage coronarien avec MIECC)

Chirurgie aortique (réparation d'anévrisme de l'aorte thoracique)

Remplacement ou réparation de la valve aortique (mini-invasive, TAVI)

Chirurgie de la valve mitrale (remplacement ou réparation)

Transplantation cardiaque

Adhésions

Membre fondateur de la Société chypriote des chirurgiens cardiothoraciques (CSCTS) fondée en 2023.

Membre de l'Association européenne de chirurgie cardiothoracique (EACTS)

Membre de la Société de chirurgie cardiothoracique (SCTS) en Grande-Bretagne et en Irlande

Inscription au Ministère de la Santé de Chypre en tant que Spécialiste en Chirurgie Cardiaque (2016)

Registre des spécialistes du GMC-UK : chirurgie cardiothoracique (2014)

Ordre des médecins italiens (Ordre des médecins et chirurgiens) : inscription complète avec permis d'exercice (2008 – 2014)

Rawipa Khunnarong, M.D. (Dr. Praew), is a physiatrist at Police General Hospital, Bangkok (2025–present). She provides rehabilitation for musculoskeletal pain, neurological disorders, and functional impairments. She works with multidisciplinary teams and teaches and supervises residents.

Education: M.D., Rangsit University/Rajavithi Hospital (2019). Rehabilitation Medicine Residency, Phramongkutklao College of Medicine (2025). Core expertise includes pain and interventional rehabilitation, neurorehabilitation (stroke, spinal cord injury), dysphagia, and sports and exercise medicine.

Advanced training includes Sports Rehabilitation Beyond Strength (2025), PMK Dry Needling (2025), and the 3rd Musculoskeletal Intervention Course (2025). She also completed a BASEM study visit (2024), Olympus FEES for dysphagia (2024), AOCNR (2023), TRMA (2022), and Viatris programs (2022–2023).

Dr. Sirinda “Ning” Kittiprachakul is a board-certified physiatrist (Thai Board of Rehabilitation Medicine, 2025) at King Chulalongkorn Memorial Hospital. She focuses on neurorehabilitation and cardiac rehabilitation. Her expertise includes geriatric rehabilitation, chronic pain management using Western dry needling, and electrodiagnostic and electromyographic studies.

She earned her MD with First Class Honors in 2020 and completed her Rehabilitation Medicine residency in 2025. She is a Ph.D. candidate in Clinical Sciences at Chulalongkorn University. Her research includes authorship in JACC (2019) and an abstract in Gut (IDDF 2025). She trained at KNRC in Korea in 2024. She received the MDCU Congress 2023 E‑poster consolation prize. She also completed training in HMS telemedicine, Nature Masterclasses, and focused shockwave therapy.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.